Skip to content

CYTK

Cytokinetics, Incorporated

Stock

$65.62−0.29 (−0.44%)Close Oct 1, 2026

Free cash flow (TTM)−$581M

Free cash flow

PeriodFree cash flowYoY
2025−$535M—
2024−$400M—
2023−$416M—
2022−$311M—
2021−$191M—
2020−$2.1M—
2019−$94M—
2018−$102M—
2017−$105M—
2016$35M+718.9%
2015$4.3M—
2014−$46M—
2013−$8.3M—
2012−$34M—
2011−$46M—
2010−$45M—
2009$7.9M—